Research Education About Cancer and Health (REACH) Core
关于癌症与健康的研究教育 (REACH) 核心
基本信息
- 批准号:10756839
- 负责人:
- 金额:$ 16.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-30 至 2028-08-31
- 项目状态:未结题
- 来源:
- 关键词:Academic supportAdvanced Malignant NeoplasmAdvisory CommitteesAreaBiological SciencesBiomedical ResearchCancer BiologyCancer health equityCareer MobilityCollaborationsCommunicationCommunitiesCreativenessDevelopmentDisciplineEducationEducational ActivitiesEffectivenessEnvironmentEthnic PopulationEvaluationExclusionFeedbackFundingFutureGoalsGrantHealthHealth Disparities ResearchIndividualInstitutionInternshipsJointsKnowledgeMalignant NeoplasmsMeasuresMotivationNamesParticipantPositioning AttributeProcessProgram EvaluationPublic HealthPublic Health SchoolsRecommendationResearchResearch PersonnelResearch Project GrantsResearch SupportResourcesScienceScientistStudentsTrainingTraining ProgramsTraining and EducationUniversitiesWashingtonWorkanticancer researchcancer health disparitydesigneducation researchequity, diversity, and inclusionexperienceformative assessmentgraduate studenthealth disparityhealth equityimprovedinnovationinterestlearning communitymeetingsmembernext generationpopulation healthprogramspublic health researchresponserole modelskillssocial groupsuccesssynergismtoolundergraduate studentunderserved community
项目摘要
ABSTRACT
The Partnership Research Education About Cancer and Health (REACH) Core will deliver research
education activities in cancer and health disparities and prepare future scientists to contribute to the
diversification of the biomedical research workforce. The REACH Core has demonstrated exceptional success
in training undergraduate and graduate students, including individuals from Historically Excluded Communities
(HECs) in previous U54 Partnership funding cycles. Based on its experience implementing a variety of
research education programs such as undergraduate (Cancer Research Internship for NMSU Undergraduates;
CRI-U) and graduate (Cancer Research Internship for NMSU Graduates; CRI-G) research internships,
Graduate Health Disparities Course (University of Washington, School of Public Health), and the Health
Disparities Field Experience (renamed the Health Equity Field Experience in the U54-IV), the Partnership will
implement integrated biomedical research education programs with an emphasis on cancer and/or health
disparities research, across a spectrum of academic levels to diversify the scientific workforce contributing to
biomedical and population health research. The Partnership will also provide concurrent and on-going support
for academic and professional goal attainment among all its participants. Formative assessments to measure
strengths and inform areas for improvement of research education activities will be carried out with the
Planning & Evaluation Core. The Partnership will continue to use long-term tracking tools to offer sustained
support to participants and evaluate impact and effectiveness of activities. In response to past program
evaluation and recommendations from the Internal Advisory Committee and external Program Steering
Committee, a portfolio of activities is proposed that prioritize the current needs to promote and heighten cancer
research education that is focused on undergraduate and graduate students at both institutions.
The REACH Core will implement education programs across academic levels and disciplines; provide support
for trainees’ goal attainment that identifies individual-specific needs and interests, opportunities as well as
potential barriers to career advancement; design experiences for trainees that create a sense of community
and belonging both within the Partnership and more broadly in the larger scientific community, and; conduct
assessments of research education activities’ effectiveness, including long-term tracking, to identify
opportunities for innovation and needs for improvement while meeting the diverse needs of participants. These
activities will contribute to the Partnership’s Aims of diversifying the biomedical workforce, creating a more
inclusive and affirmative research environment and enhancing cancer health equity.
摘要
关于癌症和健康的伙伴关系研究教育(REACH)核心将提供研究
癌症和健康差距的教育活动,并准备未来的科学家,
生物医学研究队伍的多样化。REACH核心已经证明了非凡的成功
培训本科生和研究生,包括来自历史上被排斥的社区的个人
(HEC)在U 54伙伴关系以前的供资周期中。根据其实施各种
研究教育计划,如本科(癌症研究实习NMSU本科生;
CRI-U)和研究生(NMSU毕业生癌症研究实习; CRI-G)研究实习,
研究生健康差异课程(华盛顿大学公共卫生学院)和健康
差异实地经验(在U 54-IV中更名为健康公平实地经验),该伙伴关系将
实施以癌症和/或健康为重点的综合生物医学研究教育计划
差异研究,在一系列的学术水平,以多样化的科学劳动力有助于
生物医学和人口健康研究。该伙伴关系还将提供并行和持续的支持
促进所有参与者实现学术和专业目标。形成性评估,
优势和信息领域的研究教育活动的改进将进行与
规划和评估核心。伙伴关系将继续使用长期跟踪工具,
支持参与者并评估活动的影响和有效性。针对过去的方案
内部咨询委员会和外部计划指导的评估和建议
委员会,提出了一系列活动,优先考虑目前的需要,以促进和提高癌症
研究教育,重点是在这两个机构的本科生和研究生。
REACH核心将实施跨学术水平和学科的教育计划;
为学员的目标实现,确定个人的具体需要和兴趣,机会,以及
职业发展的潜在障碍;为学员设计创造社区感的体验
并属于伙伴关系内部和更广泛的科学界,以及;
评估研究教育活动的有效性,包括长期跟踪,
创新的机会和改进的需要,同时满足参与者的各种需求。这些
这些活动将有助于实现伙伴关系的目标,即生物医学劳动力多样化,
包容性和积极的研究环境和增强癌症健康公平性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Julian A Simon其他文献
Julian A Simon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Julian A Simon', 18)}}的其他基金
Inhibition of B-Catenin Signaling for Treatment of Hepatocellular Carcinoma
抑制 B-连环蛋白信号转导治疗肝细胞癌
- 批准号:
8078972 - 财政年份:2010
- 资助金额:
$ 16.57万 - 项目类别:
Inhibition of B-Catenin Signaling for Treatment of Hepatocellular Carcinoma
抑制 B-连环蛋白信号转导治疗肝细胞癌
- 批准号:
7990951 - 财政年份:2010
- 资助金额:
$ 16.57万 - 项目类别:
Chemoprotection Against Aminoglycoside-Induced Ototoxicity
针对氨基糖苷类药物引起的耳毒性的化学保护
- 批准号:
8515203 - 财政年份:2009
- 资助金额:
$ 16.57万 - 项目类别:
Chemoprotection Against Aminoglycoside-Induced Ototoxicity
针对氨基糖苷类药物引起的耳毒性的化学保护
- 批准号:
7729834 - 财政年份:2009
- 资助金额:
$ 16.57万 - 项目类别:
Chemoprotection Against Aminoglycoside-Induced Ototoxicity
针对氨基糖苷类药物引起的耳毒性的化学保护
- 批准号:
8118073 - 财政年份:2009
- 资助金额:
$ 16.57万 - 项目类别:
Chemoprotection Against Aminoglycoside-Induced Ototoxicity
针对氨基糖苷类药物引起的耳毒性的化学保护
- 批准号:
8545455 - 财政年份:2009
- 资助金额:
$ 16.57万 - 项目类别:
Chemoprotection Against Aminoglycoside-Induced Ototoxicity
针对氨基糖苷类药物引起的耳毒性的化学保护
- 批准号:
7914280 - 财政年份:2009
- 资助金额:
$ 16.57万 - 项目类别:
Chemoprotection Against Aminoglycoside-Induced Ototoxicity
针对氨基糖苷类药物引起的耳毒性的化学保护
- 批准号:
8288091 - 财政年份:2009
- 资助金额:
$ 16.57万 - 项目类别:
Chemoprotection Against Aminoglycoside-Induced Ototoxicity
针对氨基糖苷类药物引起的耳毒性的化学保护
- 批准号:
8604242 - 财政年份:2009
- 资助金额:
$ 16.57万 - 项目类别:
Partnership for the Advancement of Cancer Research: NMSU-FHCRC (2 of 2)
促进癌症研究合作伙伴关系:NMSU-FHCRC(2 of 2)
- 批准号:
9342672 - 财政年份:2007
- 资助金额:
$ 16.57万 - 项目类别: